Evidence map›Paper›PMID 40703360›Full record

ArticleFrontiers in pharmacology2025

Prediction of drug concentrations in humans for long-acting injectable suspensions by a semi-mechanical muscle compartment model: a case study of paliperidone palmitate.

Panpan Yu, Mengjun Zhang, Xiong Jin, Keheng Wu, Sihui Long, Shishi Cheng, Long Fu, Xiao Xu, Jie Liu, Dan Liu and 3 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Panpan Yu *Livzon Pharmaceutical Group Inc., Livzon Corporate, Zhuhai, Guangdong, China.
Mengjun Zhang *School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China.
Xiong JinSchool of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China.
Keheng WuYinghan Pharmaceutical Technology (Shanghai) Co., Ltd., Shanghai, China.
Sihui LongSchool of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China.
Shishi ChengYinghan Pharmaceutical Technology (Shanghai) Co., Ltd., Shanghai, China.
Long FuLivzon Pharmaceutical Group Inc., Livzon Corporate, Zhuhai, Guangdong, China.
Xiao XuLivzon Pharmaceutical Group Inc., Livzon Corporate, Zhuhai, Guangdong, China.
Jie LiuLivzon Pharmaceutical Group Inc., Livzon Corporate, Zhuhai, Guangdong, China.
Dan LiuYinghan Pharmaceutical Technology (Shanghai) Co., Ltd., Shanghai, China.
Xue LiYinghan Pharmaceutical Technology (Shanghai) Co., Ltd., Shanghai, China.
Bo LiuSchool of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan, China.
Jian XuLivzon Pharmaceutical Group Inc., Livzon Corporate, Zhuhai, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-acting injectable formulations, such as paliperidone palmitate extended-release injectable suspension, have been designed to release medicines slowly and sustainably. Developing models that simulate drug release from long-acting injectable formulations

Indexed as

long-acting injectablenanocrystalspaliperidoneprediction in human subjectssemi-mechanical muscle compartment model

Identifiers

PMID40703360
PMCPMC12284281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.